CVR: 28865880
FORWARD PHARMA A/S was a Danish company of the type Aktieselskab based in Hellerup, founded in 2005 and dissolved in 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 4 employees. In 2024, the company reported a gross profit of DKK -9,457,909 and a net result of DKK 75,927,645 compared with DKK -3,832,516 the year before. Equity amounted to DKK 488,330,233.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | - | 75.9 mio. | 835.4 mio. | 488.3 mio. | 2 | |
| 2023 | - | -3.8 mio. | 704.7 mio. | 426.4 mio. | 2 | |
| 2022 | - | -31.5 mio. | 529.9 mio. | 430.4 mio. | 2 | |
| 2021 | - | -12.3 mio. | 561.1 mio. | 461.9 mio. | 2 | |
| 2020 | - | -42.2 mio. | 574.9 mio. | 474.1 mio. | 2 | |
| 2019 | - | -28.5 mio. | 613.1 mio. | 515.9 mio. | 3 | |
| 2018 | 0 | -54.3 mio. | 539.9 mio. | 534.6 mio. | 3 | |
| 2017 | 1.3 mia. | 880.2 mio. | 173.8 mio. | 89.4 mio. | - | |
| 2016 | - | 2 mio. | 199.2 mio. | 189.7 mio. | - | |
| 2015 | - | -51.1 mio. | 179.9 mio. | 176.7 mio. | - | |
| 2014 | - | -13.7 mio. | 240.3 mio. | 238 mio. | - | |
| 2012 | - | 22.4 mio. | 64.9 mio. | 50.4 mio. | - |
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorCompared to 1.052 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
As of November 26, 2025, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of FORWARD PHARMA A/S.
As of November 26, 2025, Jakob Mosegaard Larsen has stepped down as liquidator of FORWARD PHARMA A/S.
On November 26, 2025, FORWARD PHARMA A/S exited liquidation.
FORWARD PHARMA A/S was dissolved on November 26, 2025.
FORWARD PHARMA A/S has published its annual report for 2024. Gross profit came to DKK -9,457,909, and the net result was DKK 75,927,645.
As of February 25, 2025, Jakob Mosegaard Larsen has left the board of directors of FORWARD PHARMA A/S.
As of February 25, 2025, Grant Hellier Lawrence has left the board of directors of FORWARD PHARMA A/S.
As of February 25, 2025, Duncan Moore has left the board of directors of FORWARD PHARMA A/S.
As of February 25, 2025, Jakob Mosegaard Larsen is registered as liquidator of FORWARD PHARMA A/S.
As of February 25, 2025, Claus Bo Søndergaard Svendsen has stepped down as director of FORWARD PHARMA A/S.
As of February 25, 2025, Florian Schønharting has stepped down as chairman of FORWARD PHARMA A/S.
On February 25, 2025, FORWARD PHARMA A/S entered liquidation.
As of September 4, 2024, Torsten Goesch has left the board of directors of FORWARD PHARMA A/S.
FORWARD PHARMA A/S has published its annual report for 2023. Gross profit came to DKK -6,130,606, and the net result was DKK -3,832,516.
FORWARD PHARMA A/S has published its annual report for 2022. Gross profit came to DKK -11,631,794, and the net result was DKK -31,482,847.
As of June 8, 2023, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of FORWARD PHARMA A/S.
As of June 8, 2023, EY Godkendt Revisionspartnerselskab has stepped down as auditor of FORWARD PHARMA A/S.
FORWARD PHARMA A/S has published its annual report for 2021. Gross profit came to DKK -10,812,930, and the net result was DKK -12,271,137.
FORWARD PHARMA A/S has published its annual report for 2020. Gross profit came to DKK -7,763,728, and the net result was DKK -42,201,691.
FORWARD PHARMA A/S has published its annual report for 2019. Gross profit came to DKK -5,969,155, and the net result was DKK -28,465,258.
FORWARD PHARMA A/S has published its annual report for 2018. Revenue came to DKK 0, and the net result was DKK -54,294,876.
FORWARD PHARMA A/S has published its annual report for 2017. Revenue came to DKK 1,250,000,000, and the net result was DKK 880,210,000.
As of July 31, 2017, Rupert Sandbrink has stepped down as director of FORWARD PHARMA A/S.
FORWARD PHARMA A/S has published its annual report for 2016. The net result was DKK 2,032,000.
As of May 3, 2017, Johannes Gerardus Joseph van de Winkel has left the board of directors of FORWARD PHARMA A/S.
As of May 3, 2017, Karen Lesley Smith has left the board of directors of FORWARD PHARMA A/S.
As of April 30, 2017, Joel David Sendek has stepped down as økonomidirektør of FORWARD PHARMA A/S.
As of March 1, 2017, Claus Bo Søndergaard Svendsen is registered as director of FORWARD PHARMA A/S.
As of March 1, 2017, Peder Møller Andersen has stepped down as director of FORWARD PHARMA A/S.
FORWARD PHARMA A/S has published its annual report for 2015. The net result was DKK -51,065,000.
As of May 6, 2016, Karen Lesley Smith has joined the board of directors of FORWARD PHARMA A/S.
As of May 6, 2016, Duncan Moore has joined the board of directors of FORWARD PHARMA A/S.
As of May 6, 2016, John Kevin Buchi has left the board of directors of FORWARD PHARMA A/S.
As of March 1, 2016, Rupert Sandbrink is registered as director of FORWARD PHARMA A/S.
As of July 20, 2015, Jakob Mosegaard Larsen has joined the board of directors of FORWARD PHARMA A/S.
As of July 20, 2015, Grant Hellier Lawrence has joined the board of directors of FORWARD PHARMA A/S.
FORWARD PHARMA A/S has published its annual report for 2014. The net result was DKK -13,662,000.
As of October 10, 2014, EY Godkendt Revisionspartnerselskab has been appointed auditor of FORWARD PHARMA A/S.
As of October 10, 2014, JUT NR. 2180 A/S has stepped down as auditor of FORWARD PHARMA A/S.
As of August 13, 2014, Johannes Gerardus Joseph van de Winkel has joined the board of directors of FORWARD PHARMA A/S.
As of August 5, 2014, Joel David Sendek is registered as økonomidirektør of FORWARD PHARMA A/S.
As of August 5, 2014, Joel David Sendek is registered as økonomidirektør of FORWARD PHARMA A/S.
As of August 5, 2014, Joel David Sendek has stepped down as økonomidirektør of FORWARD PHARMA A/S.
FORWARD PHARMA A/S has published its annual report for 2013.
FORWARD PHARMA A/S has published its annual report for 2012. Gross profit came to DKK -10,966,924, and the net result was DKK 22,400,979.
As of December 8, 2012, John Kevin Buchi has joined the board of directors of FORWARD PHARMA A/S.
As of December 8, 2012, Hans Thalsgård Schambye has left the board of directors of FORWARD PHARMA A/S.
As of May 1, 2012, Peder Møller Andersen is registered as director of FORWARD PHARMA A/S.
As of April 30, 2012, Morten Priskorn has stepped down as director of FORWARD PHARMA A/S.
As of January 9, 2012, Florian Schønharting is registered as chairman of FORWARD PHARMA A/S.
As of January 9, 2012, Wyle David Solomon has stepped down as chairman of FORWARD PHARMA A/S.
As of July 13, 2011, JUT NR. 2180 A/S has been appointed auditor of FORWARD PHARMA A/S.
As of July 13, 2011, EY Danmark A/S has stepped down as auditor of FORWARD PHARMA A/S.
As of December 2, 2010, Morten Priskorn is registered as director of FORWARD PHARMA A/S.
As of December 2, 2010, Lars Folke Henrik Nilsson has stepped down as director of FORWARD PHARMA A/S.
As of June 15, 2010, Hans Thalsgård Schambye has joined the board of directors of FORWARD PHARMA A/S.
As of June 15, 2010, Christian Karsten Hansen has left the board of directors of FORWARD PHARMA A/S.
As of June 15, 2010, Florian Schønharting has left the board of directors of FORWARD PHARMA A/S.
As of June 15, 2010, Wyle David Solomon is registered as chairman of FORWARD PHARMA A/S.
As of October 21, 2008, Marianne Kock has left the board of directors of FORWARD PHARMA A/S.
As of September 18, 2006, Lars Folke Henrik Nilsson has left the board of directors of FORWARD PHARMA A/S.
As of September 18, 2006, Lars Folke Henrik Nilsson is registered as director of FORWARD PHARMA A/S.
As of September 18, 2006, Morten Priskorn has stepped down as director of FORWARD PHARMA A/S.
As of June 9, 2006, Torsten Goesch has joined the board of directors of FORWARD PHARMA A/S.
As of July 1, 2005, EY Danmark A/S has been appointed auditor of FORWARD PHARMA A/S.
As of July 1, 2005, Christian Karsten Hansen has joined the board of directors of FORWARD PHARMA A/S.
As of July 1, 2005, Florian Schønharting has joined the board of directors of FORWARD PHARMA A/S.
As of July 1, 2005, Marianne Kock has joined the board of directors of FORWARD PHARMA A/S.
As of July 1, 2005, Lars Folke Henrik Nilsson has joined the board of directors of FORWARD PHARMA A/S.
As of July 1, 2005, Morten Priskorn is registered as director of FORWARD PHARMA A/S.
FORWARD PHARMA A/S was founded on July 1, 2005.
Companies in the same industry and area
CVR 26392861
CVR 41366044
CVR 32971024
CVR 42666084
CVR 27701396
companydata.dk